Page 69 - Read Online

Page 8 of 8 Malherbe et al. Rare Dis Orphan Drugs J 2024;3:24 https://dx.doi.org/10.20517/rdodj.2024.11

14. Skrinska V, Khneisser I, Schielen P, Loeber G. Introducing and expanding newborn screening in the MENA region. Int J Neonatal
Screen 2020;6:12. DOI PubMed PMC
15. EUROPLAN. European project for rare diseases national plans development. Available from: http://www.europlanproject.eu/
Events?idEventType=13 [Last accessed on 13 Aug 2024].
16. Department: statistics South Africa. General Household Survey 2022. Available from: https://www.statssa.gov.za/publications/P0318/
P03182022.pdf [Last accessed on 15 Aug 2024].
17. Malherbe HL, Bonham J, Carrihill M, et al. Newborn screening in South Africa: the past, present, and plans for the future. Rare Dis
Orphan Drugs J 2024;3:7. DOI
18. Jain R. Rare diseases in Asia and the Pacific must be tackled too. 2020. Available from: https://www.asiapathways-adbi.org/2020/07/
rare-diseases-asia-pacific-must-be-tackled-too/ [Last accessed on 13 Aug 2024].
19. Jain R, Wang CM, Foster L, Li EY, Nishimura Y, Tsang KP. Paradox of possibilities: the rare landscape in the Asia Pacific region.
Rare Dis Orphan Drugs J 2024;3:8. DOI
20. National Health Security Office. Tandem mass spectrometry newborn screening is available nationwide. 2023. Available from: http://
eng.nhso.go.th/view/1/DescriptionNews/Tandem-mass-spectrometry-newborn-screening-is-available-nationwide/555/EN-US [Last
accessed on 13 Aug 2024][.
21. Tajima T. Newborn screening in Japan-2021. Int J Neonatal Screen 2022;8:3. DOI PubMed PMC
22. Kapoor S, Gupta AK, Thelma BK. Charting the course: towards a comprehensive newborn screening program in India. Int J Neonatal
Screen 2024;10:43. DOI PubMed PMC
23. Padilla CD, Therrell BL Jr, Alcausin MMLB, et al. Successful implementation of expanded newborn screening in the Philippines using
tandem mass spectrometry. Int J Neonatal Screen 2022;8:8. DOI PubMed PMC
24. Wilaiwongsathien K, Wattanasirichaigoon D, Rattanasiri S, Aonnuam C, Tangshewinsirikul C, Tim-Aroon T. Parental awareness,
knowledge, and attitudes regarding current and future newborn bloodspot screening: the first report from Thailand. Int J Neonatal
Screen 2023;9:25. DOI PubMed PMC
25. Padilla CD, Abadingo ME, Munda KV, Therrell BL. Overcoming challenges in sustaining newborn screening in low-middle-income
countries: the Philippine newborn screening system. Rare Dis Orphan Drugs J 2023;2:27. DOI
26. Millis N. View from inside: patient advocacy in guiding policy development for metabolic disorders. J Inherit Metab Dis 2022;45:866-
71. DOI PubMed
27. Taiwan Foundation for Rare Disorders. Summary of 2022 annual report. Available from: https://www.tfrd2.org.tw/tfrd_eng/index.php/
tfrd3/annual_content/id/20 [Last accessed on 13 Aug 2024].
28. Chien YH, Hwu WL. The modern face of newborn screening. Pediatr Neonatol 2023;64 Suppl 1:S22-9. DOI PubMed
29. Rare Voices Australia. Department of health and aged care publishes its ‘Newborn bloodspot screening expansion - readiness
assessment executive summary’. 2024. Available from: https://rarevoices.org.au/department-of-health-and-aged-care-publishes-its-
newborn-bloodspot-screening-expansion-readiness-assessment-executive-summary/ [Last accessed on 13 Aug 2024].
30. EURORDIS. Key principles for newborn screening. Available from: https://www.eurordis.org/publications/key-principles-for-
newborn-screening/ [Last accessed on 13 Aug 2024].
31. EURORDIS. Major survey reveals rare disease community’s overwhelming support for screening at birth. 2024. Available from:
https://www.eurordis.org/newborn-screening-survey/ [Last accessed on 13 Aug 2024].
32. Dangouloff T, Vrščaj E, Servais L, Osredkar D; SMA NBS World Study Group. Newborn screening programs for spinal muscular
atrophy worldwide: where we stand and where to go. Neuromuscul Disord 2021;31:574-82. DOI PubMed
33. European Alliance for Newborn Screening in SMA. Spinal muscular atrophy: Screen at birth, save lives. 2021. Available from: https://
nbs-alliance-assets.gpm.digital/Spinal_muscular_atrophy_Screen_at_birth_save_lives_Whitepaper_SMA_NBS_Alliance_v2_25_
NOV_2021_aa4fca4159.pdf [Last accessed on 15 Aug 2024]
34. Yska HAF, Henneman L, Barendsen RW, Engelen M, Kemp S. Attitudes of patients with adrenoleukodystrophy towards sex-specific
newborn screening. Int J Neonatal Screen 2023;9:51. DOI PubMed PMC
35. Giugliani R, Castillo Taucher S, Hafez S, et al. Opportunities and challenges for newborn screening and early diagnosis of rare
diseases in Latin America. Front Genet 2022;13:1053559. DOI PubMed PMC
36. Laugwitz L, Schoenmakers DH, Adang LA, et al. Newborn screening in metachromatic leukodystrophy - European consensus-based
recommendations on clinical management. Eur J Paediatr Neurol 2024;49:141-54. DOI
37. Dawkins HJS, Draghia-Akli R, Lasko P, et al; International Rare Diseases Research Consortium (IRDiRC). Progress in rare diseases
research 2010-2016: an IRDiRC perspective. Clin Transl Sci 2018;11:11-20. DOI PubMed PMC
38. van Lin N, Paliouras G, Vroom E, 't Hoen PAC, Roos M. How patient organizations can drive FAIR data efforts to facilitate research
and health care: a report of the virtual second international meeting on duchenne data sharing, March 3, 2021. J Neuromuscul Dis
2021;8:1097-108. DOI PubMed PMC
39. Gallin EK, Bond E, Califf RM, et al. Forging stronger partnerships between academic health centers and patient-driven organizations.
Acad Med 2013;88:1220-4. DOI
40. Sikonja J, Groselj U, Scarpa M, et al. Towards achieving equity and innovation in newborn screening across Europe. Int J Neonatal
Screen 2022;8:31. DOI PubMed PMC